+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac POC Testing Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 377 Pages
  • February 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139739

Global Cardiac POC Testing Devices Market to Reach $2.2 Billion by 2030

The global market for Cardiac POC Testing Devices estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$2.2 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2022-2030. Cardiac Markers Test, one of the segments analyzed in the report, is projected to record 5.7% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Analyzers segment is estimated at 4.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $531.4 Million, While China is Forecast to Grow at 6.7% CAGR

The Cardiac POC Testing Devices market in the U.S. is estimated at US$531.4 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$258.4 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 5.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Select Competitors (Total 50 Featured)

  • Abbott Laboratories, Inc.
  • Danaher Corporation
  • HemoCue AB
  • Alfa Scientific Designs, Inc.
  • BG Medicine, Inc.
  • Boditech Med, Inc.
  • Jant Pharmacal Corporation
  • Creative Diagnostics
  • AccuBioTech Co., Ltd.
  • BIOBASE
  • DiaSys Diagnostics India Pvt., Ltd.
  • Biosynex SA
  • Humasis Co Ltd
  • Diagnoptics
  • CTK Biotech, Inc.

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and trademarked research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes
Frequently Asked Questions about the Cardiac POC Testing Devices Market

What is the estimated value of the Cardiac POC Testing Devices Market?

The Cardiac POC Testing Devices Market was estimated to be valued at $1.4 Billion in 2022.

What is the growth rate of the Cardiac POC Testing Devices Market?

The growth rate of the Cardiac POC Testing Devices Market is 5.8%, with an estimated value of $2.2 Billion by 2030.

What is the forecasted size of the Cardiac POC Testing Devices Market?

The Cardiac POC Testing Devices Market is estimated to be worth $2.2 Billion by 2030.

Who are the key companies in the Cardiac POC Testing Devices Market?

Key companies in the Cardiac POC Testing Devices Market include Abbott Laboratories, Inc., Danaher Corporation, HemoCue AB, Alfa Scientific Designs, Inc., BG Medicine, Inc., Boditech Med, Inc., Jant Pharmacal Corporation, Creative Diagnostics, AccuBioTech Co., Ltd. and BIOBASE.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Cardiac POC Testing Devices - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • A Prelude to Cardiac POC Testing
  • Impact of Covid-19 and a Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Impact of COVID-19 on Cardiac POCT Testing Market
  • Global Market Prospects and Outlook
  • Cardiac POC Testing Market Set to Record Strong Growth Led by Advancements in Cardiac Marker Testing
  • Cardiac Marker Tests Dominate the Cardiac POC Testing Market
  • North America Corners Major Share, Asia-Pacific to Record Fastest Growth
  • Competition
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence, Mounting Economic and Social Burden of Cardiovascular Disease to Drive Market Growth
  • Leading Causes of Mortality Worldwide: Number of Deaths in Millions & % Share of Deaths by Cause for 2017
  • Leading Causes of Mortality for Low-Income and High-Income Countries
  • Aging Global Population at High Risk of Cardiac Illnesses Present Favorable Outlook for Cardiac POC Testing Devices
  • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
  • Technological Advances to Drive the Cardiac POC Diagnostics Market
  • An Overview of Available Quantitative and Qualitative POC Devices for Measuring Multiple Cardiac Markers
  • Increasing Demand for Troponin Tests Drive the Cardiac POC Market
  • Evolution of the Troponin Assay
  • Implementation of Unique & new Troponin-Based Tests Helps in Diagnosing MI
  • Optimizing Novel Troponin Assay Benefits
  • Troponin Applications: A Promising Future
  • Brain Natriuretic Peptide (BNP) Test Registers Significant Growth
  • Myoglobin Test
  • Myoglobin Test
  • Cardiac Biomarker Play Critical Role in Stroke Diagnosis
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Cardiac POC Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 3: World 16-Year Perspective for Cardiac POC Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Cardiac Markers Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Cardiac Markers Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 6: World 16-Year Perspective for Cardiac Markers Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 9: World 16-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals & Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Hospitals & Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 12: World 16-Year Perspective for Hospitals & Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 15: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • TABLE 19: World Cardiac POC Testing Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 22: USA 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 23: USA Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 27: Canada Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 28: Canada 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • TABLE 38: China Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 39: China Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 40: China 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 41: China Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 43: China 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 45: Europe Historic Review for Cardiac POC Testing Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 46: Europe 16-Year Perspective for Cardiac POC Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • TABLE 53: France Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 54: France Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 55: France 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 56: France Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 58: France 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 60: Germany Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 61: Germany 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
  • TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 66: Italy Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 67: Italy 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • TABLE 71: UK Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 72: UK Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 73: UK 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 74: UK Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • SPAIN
  • TABLE 77: Spain Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 78: Spain Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 79: Spain 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 80: Spain Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 82: Spain 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • RUSSIA
  • TABLE 83: Russia Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 84: Russia Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 85: Russia 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 86: Russia Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 88: Russia 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
  • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 90: Rest of Europe Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 91: Rest of Europe 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 94: Rest of Europe 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • TABLE 96: Asia-Pacific Historic Review for Cardiac POC Testing Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 97: Asia-Pacific 16-Year Perspective for Cardiac POC Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2014, 2023 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2014, 2023 & 2030
  • AUSTRALIA
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
  • INDIA
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Danaher Corporation
  • HemoCue AB
  • Alfa Scientific Designs, Inc.
  • BG Medicine, Inc.
  • Boditech Med, Inc.
  • Jant Pharmacal Corporation
  • Creative Diagnostics
  • AccuBioTech Co., Ltd.
  • BIOBASE
  • DiaSys Diagnostics India Pvt., Ltd.
  • Biosynex SA
  • Humasis Co Ltd
  • Diagnoptics
  • CTK Biotech, Inc.